Category: Tuberculosis
Asia Tuberculosis
-
2024-2029 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
Tuberculosis Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Tuberculosis Treatment Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Tuberculosis Treatment Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
TB Diagnostic Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global TB diagnostic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global TB ... Read More
-
2024 Global Tuberculosis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
Asia Pacific Bovine Diagnostics Market Forecast to 2030 – Regional Analysis – by Product [Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products], Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users)
... (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Type], and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) The Asia Pacific bovine diagnostics market is expected to grow from US$ 250.42 ... Read More
-
Bacterial Vaccines Market, By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, and Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, and Geriatric Vaccines), By Route of Administration (Intramuscular, Intravenous, Subcutaneous, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Infants, Children), Adolescent Vaccines, Adult Vaccines, and Geriatric Vaccines), By Route of Administration (Intramuscular, Intravenous, Subcutaneous, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East ... Read More
-
Infectious Disease Diagnostics Market, By Technique ( ELISA, Polymerase Chain Reaction (PCR),Immunoassays, Cell Cultures, Others),By Disease Indication (CNS Infection ,Meningitis, Brain Abscess), Diarrheal Disease ( Shigellosis, Cholera, Enteric/Typhoid Fever),Respiratory Infections(Tuberculosis, Influenza, Bronchitis),Blood Infections(Malaria, Dengue, Infectious Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - ... Read More
-
Veterinary Tuberculosis Vaccine Market, by Type (Live Attenuated, Inactivated), by Route of Administration (Sub-cutaneous, Intramuscular, Oral), by Animal Type (Cattle, Dogs, Cats, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly ... Read More
-
Asia Pacific Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The APAC anti-infective agents market was valued at US$ 35,281.27 million in 2022 and ... Read More